Metraipolis › archive › dc_4cbf6d2a85ed
Evaluating "brain permeability": A critical issue for the development of therapeutic agents for primary and metastatic brain tumors — Europe PMC PMID:41818680
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41818680
- DOI
- 10.1093/neuonc/noag051
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T13:58:12.564Z
- SHA-256 of the archived text
74db85a5309fb58832271ff46d76b2a37bd6d789efc83b707cec9d73119d3bdd- Stable URL of this page
https://metraipolis.com/documento/dc_4cbf6d2a85ed
How to cite
Evaluating "brain permeability": A critical issue for the development of therapeutic agents for primary and metastatic brain tumors — Europe PMC PMID:41818680 — Europe PMC (en), https://europepmc.org/article/MED/41818680 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4cbf6d2a85ed (Metraipolis archive dc_4cbf6d2a85ed, sha256 74db85a5309fb58832271ff46d76b2a37bd6d789efc83b707cec9d73119d3bdd)
BibTeX
@misc{dc4cbf6d2a85ed,
title = {Evaluating "brain permeability": A critical issue for the development of therapeutic agents for primary and metastatic brain tumors — Europe PMC PMID:41818680},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41818680},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4cbf6d2a85ed; sha256 74db85a5309fb58832271ff46d76b2a37bd6d789efc83b707cec9d73119d3bdd},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41818680. Agents can read the archived copy with the MCP tool read_document.